Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Severe Acute Respiratory Syndrome

cetylpyridinium chloride anhydrous has been researched along with Severe Acute Respiratory Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Disthakumpa, A; Moolasart, V; Srijareonvijit, C; Srikirin, P; Uttayamakul, S; Vaivong, N; Wongsawat, J1
Pearson, H1

Other Studies

2 other study(ies) available for cetylpyridinium chloride anhydrous and Severe Acute Respiratory Syndrome

ArticleYear
Risk of novel coronavirus 2019 transmission from children to caregivers: A case series.
    Journal of paediatrics and child health, 2020, Volume: 56, Issue:6

    Topics: Caregivers; Child; Child, Preschool; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Outbreaks; Health; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Male; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Assessment; Sampling Studies; Severe Acute Respiratory Syndrome; Taiwan; World Health Organization

2020
Antibodies to SARS-like virus hint at repeated infections.
    Nature, 2004, Jan-15, Volume: 427, Issue:6971

    Topics: Animals; Antibodies, Viral; China; Health; Hong Kong; Humans; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Zoonoses

2004